Digoxin Toxicity: The Poisoned Pump and Its Antibody

The pump it poisons

To understand the poison you must first understand the pump. Every heart-muscle cell runs a tireless ion pump, the Na+/K+-ATPase, which throws sodium out and drags potassium in, burning ATP to keep the cell's gradients honest. Digoxin's single trick is to sit on this pump and block it. When the pump slows, sodium is no longer bailed out efficiently, so intracellular sodium rises. That extra sodium disturbs a second exchanger — the Na+/Ca2+ exchanger — which normally uses the inward sodium gradient to pump calcium out of the cell. With less of a sodium gradient to work with, it extrudes less calcium, and intracellular calcium climbs. More calcium inside the cell means a stronger contraction: this is the positive inotropy that made digitalis useful in heart failure for over two hundred years. The therapeutic effect and the toxic effect are the same mechanism, dialled to different intensities — which is exactly why the margin is so thin.

Digoxin does one more thing that shapes its whole clinical picture: it raises vagal (parasympathetic) tone on the heart's conduction system. That vagal effect slows the sinus node and, above all, drags on the AV node — which is precisely why the drug is used to rein in the ventricular rate in atrial fibrillation. But push it too far and the same vagal drag becomes pathological AV block. So digoxin is doing two things at once: loading cells with calcium (which makes them twitchy and prone to fire on their own — increased automaticity) while simultaneously blocking conduction through the AV node. Hold those two ideas together, because their collision is the fingerprint of digoxin toxicity.

Two poisonings, one drug: acute versus chronic

Acute overdose and chronic accumulation are almost different diseases. Acute toxicity is usually a large deliberate ingestion — a suicidal overdose, or occasionally an accidental one in a child. The patient may have been perfectly healthy an hour ago. Vomiting comes early, and the standout laboratory feature is HYPERkalaemia. This is the crucial teaching point: when the Na+/K+-ATPase is massively blocked all over the body, potassium can no longer be pumped into cells, so it leaks out into the blood. The height of the serum potassium tracks the number of poisoned pumps — which is why, in acute poisoning, potassium is one of the best markers of severity and prognosis. In the era before the antidote, a serum potassium above roughly 5.5 mmol/L predicted a very high mortality. Hyperkalaemia here is not a coincidence; it is the whole-body signature of the poisoned pump.

Chronic toxicity is the quieter, commoner story — and the one in our opening scene. It creeps up on an elderly patient taking digoxin long-term, and the trigger is almost always something that either raises the drug level or sensitises the heart to it. Renal impairment is the classic culprit: digoxin is cleared by the kidneys, so a dip in renal function (dehydration, an infection, a new NSAID) lets the drug accumulate at an unchanged dose. Electrolyte disturbances turn the screw further: low potassium (hypokalaemia) and low magnesium (hypomagnesaemia) — often courtesy of the very diuretics these patients take for heart failure — both dramatically worsen digoxin's toxicity, because potassium and digoxin compete for the same site on the pump, and a low potassium lets digoxin bind more freely. And interacting drugs matter: amiodarone, verapamil, quinidine and others raise digoxin levels. Here potassium is often low, not high — the opposite of acute poisoning — which is why you must know which type you are facing. These interactions and the diuretic-driven electrolyte problems are explored in the Cardiovascular / Heart Failure & Arrhythmias chapter.

The toxidrome: eyes, gut, and a treacherous rhythm

The non-cardiac clues are often what brings the patient in. The gut complains first and loudest: nausea, vomiting and anorexia are nearly universal. The nervous system contributes confusion, weakness and lethargy, especially in the elderly, where it is easily mistaken for delirium of any cause. And then the famous visual disturbance: chromatopsia — colours look wrong — classically xanthopsia, a yellow-green tinge to vision, sometimes with bright halos or blurring. Van Gogh's yellow-drenched later paintings are sometimes (speculatively) attributed to digitalis. These symptoms are soft and easily dismissed, but in a patient on digoxin they should trigger an immediate level and an ECG.

The rhythm is where digoxin kills — and it has a signature. Almost any arrhythmia can occur in digoxin toxicity — that breadth is itself a clue. But the pathognomonic pattern is the collision we set up earlier: increased automaticity together with impaired conduction. The calcium-loaded cells fire ectopic beats (increased automaticity), while the vagally-suppressed AV node blocks conduction — two things that rarely coexist from other causes. Classic examples include: paroxysmal atrial tachycardia with AV block; a "regularised" atrial fibrillation (the irregularly irregular rhythm becomes suspiciously regular because complete AV block has taken over with a junctional escape); bidirectional ventricular tachycardia — a rare, near-specific finding where the QRS axis flips beat to beat; frequent ventricular ectopics and bigeminy; and, at the severe end, high-grade AV block, bradyarrhythmias, and ventricular fibrillation. The mechanism of these delayed afterdepolarisations — calcium overload triggering spontaneous depolarisations — connects to the arrhythmia physiology taught in the Cardiovascular chapter.

Management: correct the electrolytes, respect the potassium

General measures come first. Activated charcoal may help if a large ingestion is recent (digoxin undergoes some enterohepatic recirculation), and continuous cardiac monitoring is mandatory. Bradyarrhythmias may respond to atropine; symptomatic haemodynamic instability may need temporary pacing while definitive treatment is arranged. Then attend to the electrolytes that drive the toxicity. In chronic toxicity, cautiously correct a low potassium and a low magnesium — both make the heart more irritable, and magnesium in particular can suppress digoxin-induced ectopy. But do not over-correct potassium in the acute setting, where it may already be dangerously high.

One reflex you must resist: calcium for the hyperkalaemia. Here is the classic toxicology trap. In most causes of severe hyperkalaemia, you give intravenous calcium to stabilise the cardiac membrane. But digoxin toxicity is not most causes. The cell is already calcium-overloaded — that is the whole mechanism — and there is a long-standing fear that pushing in yet more calcium could precipitate an inexcitable, contracted "stone heart" and refractory arrest. The evidence for real harm is debated, and some modern reviews argue the danger was overstated; but the far better answer, and the one that treats the poisoning rather than a single number, is the specific antidote. If digoxin toxicity is causing dangerous hyperkalaemia, the definitive treatment is not calcium — it is the antibody. The potassium handling itself (and why the ECG, not the number alone, guides you) links to the Endocrine/renal section.

The antidote: digoxin-specific antibody fragments (Fab)

This is one of the most elegant antidotes in all of toxicology. Digoxin-specific antibody fragments — the Fab (fragment, antigen-binding) portion of anti-digoxin antibodies, marketed as DigiFab — do exactly what the name promises. Raised in sheep against digoxin, then cleaved so that only the small antigen-grabbing fragment remains (less immunogenic, better distributed, renally cleared), they are infused into the poisoned patient and bind digoxin with enormous affinity. Crucially, they bind free digoxin in the blood, which shifts the equilibrium and pulls digoxin off the Na+/K+-ATPase — literally peeling the poison off the pump. The pump restarts, calcium overload resolves, and — strikingly — the hyperkalaemia of acute poisoning reverses as potassium is pumped back into cells. The bound digoxin–Fab complex is then excreted by the kidneys. Effects can begin within minutes. This class of antibody-based antidote is discussed alongside the general principles of enhanced elimination and antidotes in that dedicated chapter.

When do you reach for Fab? The indications are the features that mean the poisoning is now life-threatening: any life-threatening ventricular arrhythmia; significant, unresponsive bradyarrhythmia or high-grade AV block; a markedly raised serum potassium in acute poisoning (traditionally taken as above roughly 5.0–5.5 mmol/L, a strong prognostic threshold); haemodynamic instability; and very large ingestions or very high measured levels even before overt collapse. Dosing is worked out from either the estimated amount ingested or the measured serum level and the patient's weight, and empirical doses are used when the patient is arresting and there is no time to calculate — but the principle to remember is that you titrate to the size of the poisoning, not to a fixed dose. One vital practical caveat: after Fab is given, the standard serum digoxin assay becomes uninterpretable, because it measures total (bound + free) drug and will read spuriously high while the clinically relevant free digoxin is actually being mopped up. So you follow the patient — the rhythm, the potassium, the clinical state — not the digoxin number.